查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1702348

全球诊断影像市场 - 2025-2033

Global Diagnostic Imaging Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球诊断影像市场规模达到 299.3 亿美元，预计到 2033 年将达到 462.5 亿美元，在 2025-2033 年预测期内的复合年增长率为 4.9%。

诊断影像涵盖多种用于创建身体内部视觉表现的医疗技术，使医疗保健专业人员能够诊断、监测和治疗各种疾病。这些影像方法包括 X 光、CT 扫描、MRI、超音波和核子医学，可提供详细的影像，帮助医生识别症状的根本原因，例如疼痛、肿胀或身体检查中的异常发现。

除了诊断之外，诊断影像在监测骨折、肿瘤、感染或慢性疾病等治疗进展方面也发挥关键作用。透过提供一种非侵入性的方式来检查身体内部结构，诊断影像对于准确、及时的医疗干预和持续的患者护理至关重要。

市场动态：

驾驶员和约束装置

慢性病发生率上升

慢性病和病理疾病的日益普及对先进的诊断影像技术产生了巨大的需求。随着对早期发现併发症的需求增加，诊断影像设备市场迅速扩大。这些影像程序利用放射线照相术、超音波检查、透视检查和核子医学等技术，提供身体内部的详细视觉影像，对于诊断各种慢性疾病至关重要。透过这些方法诊断的最常见疾病包括心血管疾病、癌症、慢性呼吸系统疾病和糖尿病。

例如，根据美国国家骨质疏鬆症基金会的数据，美国有 1,020 万人患有骨质疏鬆症，女性的盛行率（16.5%）高于男性（5.1%）。此外，还有4,340万人骨量低。预计到 2030 年，将有 7,100 万成年人患有骨质疏鬆症或骨质不足。同样，美国癌症协会的《2024 年全球癌症统计报告》强调，2022 年全球诊断出约 2,000 万例新癌症病例，其中 970 万人死于癌症。到2050年，全球癌症病例数预计将上升至3,500万人。随着这些慢性疾病的不断增加，对诊断影像的需求不断增长，推动了市场的扩张。

诊断影像系统的高成本

诊断成像系统的高成本预计将对诊断成像市场的成长构成重大挑战。这些先进技术，例如 MRI 机器、CT 扫描仪和 PET 扫描仪，需要大量的前期投资用于购买和安装，以及持续的维护和营运费用。

对于许多医疗机构来说，购买和维护这些复杂系统的财务负担可能是难以承受的。因此，诊断影像系统的高成本可能会减缓市场的成长，特别是在医疗保健预算已经捉襟见肘的地区。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • 慢性病发生率上升
      • 先进产品创新不断涌现
    • 限制
      • 诊断成像系统成本高昂
      • 缺乏熟练的专业人员
    • 机会
      • 技术进步
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章：诊断影像市场（按类型）

  • 磁振造影
    • 低场MRI扫描仪
    • 高场MRI扫描仪
    • 中场MRI扫描仪
  • X射线
    • 类比成像
    • 数位影像
  • 核子医学
    • 闪烁扫描
    • PET影像
    • SPECT 影像
  • 超音波
    • 二维超音波
    • 3D/4D超音波
    • 多普勒成像
  • 断层扫描
    • 高阶切片CT扫描仪
    • 中端切片CT扫描仪
    • 低端切片CT扫描仪
  • 触觉成像
  • 功能性近红外光谱

第六章：诊断影像市场（按应用）

  • 骨科
    • 关节炎
    • 骨折和脱位
    • 骨质疏鬆症
    • 脊椎矫正术
    • 其他的
  • 神经病学
    • 脑肿瘤
    • 创伤性脑损伤
    • 脑中风
    • 其他的
  • 肿瘤学
    • 乳癌
    • 大肠直肠癌
    • 肺癌
    • 其他癌症
  • 其他的

第七章：诊断影像市场（按最终用户）

  • 诊断影像中心
  • 医院
  • 其他的

第 8 章：诊断影像市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • GE HealthCare
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • Siemens Healthineers AG
  • Carestream Health
  • Hitachi Medical Corporation
  • Canon Medical Systems Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Mindray

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: MI390

The global diagnostic imaging market reached US$ 29.93 billion in 2024 and is expected to reach US$ 46.25 billion by 2033, growing at a CAGR of 4.9% during the forecast period of 2025-2033.

Diagnostic imaging encompasses a variety of medical techniques used to create visual representations of the interior of the body, enabling healthcare professionals to diagnose, monitor, and treat various conditions. These imaging methods, which include X-rays, CT scans, MRIs, ultrasounds, and nuclear medicine, provide detailed images that help doctors identify the underlying causes of symptoms, such as pain, swelling, or unusual findings in physical exams.

Beyond diagnosis, diagnostic imaging also plays a key role in monitoring the progress of treatments for conditions like fractures, tumors, infections, or chronic diseases. By offering a non-invasive way to examine the body's internal structures, diagnostic imaging is essential for accurate, timely medical intervention and ongoing patient care.

Market Dynamics: Drivers & Restraints

Increasing Incidence of Chronic Diseases

The growing prevalence of chronic and pathological conditions has created a significant demand for advanced diagnostic imaging technologies. As the need for early detection of complications increases, the market for diagnostic imaging equipment has expanded rapidly. These imaging procedures, which utilize techniques such as radiography, ultrasonography, fluoroscopy, and nuclear medicine, provide detailed internal visuals of the body and are essential for diagnosing a variety of chronic disorders. Among the most common conditions diagnosed through these methods are cardiovascular disease, cancer, chronic respiratory disorders, and diabetes.

For example, according to the National Osteoporosis Foundation, 10.2 million people in the U.S. are affected by osteoporosis, with women experiencing a higher prevalence (16.5%) than men (5.1%). Additionally, 43.4 million people have low bone mass. It's projected that by 2030, 71 million adults will have osteoporosis or poor bone mass. Similarly, the American Cancer Society's 2024 Global Cancer Statistics report highlighted that approximately 20 million new cancer cases were diagnosed worldwide in 2022, with 9.7 million deaths attributed to the disease. By 2050, the global number of cancer cases is expected to rise to 35 million. As these chronic diseases continue to increase, the demand for diagnostic imaging continues to grow, driving the expansion of the market.

High Costs of Diagnostic Imaging Systems

The high costs associated with diagnostic imaging systems are expected to pose a significant challenge to the growth of the diagnostic imaging market. These advanced technologies, such as MRI machines, CT scanners, and PET scanners, require substantial upfront investment for purchasing and installation, as well as ongoing expenses for maintenance and operation.

For many healthcare facilities, the financial burden of acquiring and maintaining these sophisticated systems can be prohibitive. As a result, the high costs associated with diagnostic imaging systems are likely to slow down the market's growth, especially in regions where healthcare budgets are already stretched.

Segment Analysis

The global diagnostic imaging market is segmented based on type, application, end-user, and region.

MRI in the type segment is expected to dominate the diagnostic imaging market

The MRI segment is expected to hold a significant portion of the market share. This is because of their ability to produce detailed images of organs, as well as technological advances in product innovation. Magnetic resonance imaging (MRI) is a diagnostic tool that can generate detailed images of almost any structure or organ in the body.

MRI produces images on a computer using magnets and radio waves. The images produced by an MRI scan can include organs, bones, muscles, and blood arteries. Hospitals and diagnostic centers often prefer advanced, emerging, and innovative MRI solutions to diagnose diseases in the body, which is creating a demand for MRI systems.

MRI systems play a crucial role in disease detection, diagnosis, and treatment monitoring, particularly in identifying early changes in tissue and organ structures. This capability enables the earlier detection of conditions such as cancer, neurological disorders, and musculoskeletal diseases. As the prevalence of diseases affecting the brain, spinal cord, nerves, muscles, ligaments, and tendons continues to rise, there is an increasing demand for MRI technology to accurately detect, diagnose, and manage these conditions.

For instance, a 2024 report by the National Cancer Institute reveals that in the United States, over 110 million adolescents and young adults (AYAs) between the ages of 15 and 39 are living, with approximately 208,620 of them diagnosed with primary brain or spinal cord tumors. With the incidence of brain cancer expected to grow, the demand for MRI systems is anticipated to increase accordingly.

In addition, advancements in MRI technology by medical device manufacturers are expected to further propel market growth. For instance, in October 2024, FUJIFILM Healthcare Americas Corporation launched the Version 10 (v10) suite of upgrades for its ECHELON Synergy 1.5T MRI system. The v10 model integrates cutting-edge technologies, including Synergy DLR Clear, Synergy Vision with StillShot, and enhanced automated scanning capabilities, offering improved imaging precision and faster diagnostics.

With the rising number of neurological and musculoskeletal conditions, along with the ongoing innovation in MRI systems, the demand for advanced MRI solutions is poised to grow, driving the expansion of this market segment.

Geographical Analysis

North America is expected to dominate the diagnostic imaging market

The diagnostic imaging market in North America is driven by the increasing incidence of chronic diseases, the innovation of advanced systems, and also due to the presence of a large number of market players. The increasing applications of diagnostic imaging for various purposes and the presence of reimbursements in the region are expected to contribute to the region's market growth.

Moreover, North America adopts advanced technologies and systems in the healthcare industry, which could create a lucrative opportunity for the region's diagnostic imaging market growth. Cancer, cardiovascular disease, and osteoarthritis are rising among elderly individuals, raising the need and utilization of different diagnostics such as X-rays, MRIs, and CT scans. For instance, according to a report published by the Centers for Disease Control and Prevention in 2024, Heart abnormalities impact around 40,000 babies annually in the United States.

Similarly, according to the CDC revised report in 2024, approximately 53.2 million persons in the US suffer from arthritis. There are over 100 forms of arthritis, but osteoarthritis is the most common, affecting 32.5 million US people. With the rising abnormalities, the demand for diagnostic imaging rises. This transition has increased market demand for diagnostic imaging services. Healthcare providers are constantly investing in improved imaging technology to cater to this growing generation, fueling market development.

Market players in the region are increasingly innovating advanced diagnostic imaging solutions, which are expected to contribute to the region's market share. Several organizations, hospitals, and healthcare institutes are conducting mobile health services in the region, which is expected to increase the adoption of advanced diagnostic imaging systems, which could contribute to the market growth.

For instance, in August 2024, DocGo Inc. launched an innovative mobile X-ray program in partnership with MinXray. The program launched in New York City to provide rapid and accessible chest X-rays for vulnerable populations and help identify active Tuberculosis ("TB") cases. These programs increase the usage of the systems. Thus, the above factors are expected to hold the region in a significant position in the market share.

Competitive Landscape

The global market players in the diagnostic imaging market are GE HealthCare, Siemens Healthineers AG, Carestream Health, Hitachi Medical Corporation, Canon Medical Systems Corporation, Hologic, Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, Shimadzu Corporation, and Mindray, among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global diagnostic imaging market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Incidence of Chronic Diseases
      • 3.1.1.2. Rising Innovation of Advanced Products
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of the Diagnostic Imaging Systems
      • 3.1.2.2. Lack of Skilled Professionals
    • 3.1.3. Opportunity
      • 3.1.3.1. Technological Advancements
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Diagnostic Imaging Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. MRI*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Low-Field MRI Scanners
    • 5.2.4. High-Field MRI Scanners
    • 5.2.5. Mid-Field MRI Scanners
  • 5.3. X-Ray
    • 5.3.1. Analog Imaging
    • 5.3.2. Digital Imaging
  • 5.4. Nuclear Medicine
    • 5.4.1. Scintigraphy
    • 5.4.2. PET Imaging
    • 5.4.3. SPECT Imaging
  • 5.5. Ultrasound
    • 5.5.1. 2D Ultrasound
    • 5.5.2. 3D/4D Ultrasound
    • 5.5.3. Doppler Imaging
  • 5.6. Tomography
    • 5.6.1. High-End Slice CT Scanners
    • 5.6.2. Mid-End Slice CT Scanners
    • 5.6.3. Low-End Slice CT Scanners
  • 5.7. Tactile Imaging
  • 5.8. Functional Near Infrared Spectroscopy

6. Diagnostic Imaging Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Orthopedic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Arthritis
    • 6.2.4. Fractures and Dislocations
    • 6.2.5. Osteoporosis
    • 6.2.6. Spine Orthopedics
    • 6.2.7. Others
  • 6.3. Neurology
    • 6.3.1. Brain Tumors
    • 6.3.2. Traumatic Brain Injury
    • 6.3.3. Brain Stroke
    • 6.3.4. Others
  • 6.4. Oncology
    • 6.4.1. Breast Cancer
    • 6.4.2. Colorectal Cancer
    • 6.4.3. Lung Cancer
    • 6.4.4. Other Cancers
  • 6.5. Others

7. Diagnostic Imaging Market, By End User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 7.1.2. Market Attractiveness Index, By End User
  • 7.2. Diagnostic Imaging Centers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Hospitals
  • 7.4. Others

8. Diagnostic Imaging Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. GE HealthCare*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Siemens Healthineers AG
  • 10.3. Carestream Health
  • 10.4. Hitachi Medical Corporation
  • 10.5. Canon Medical Systems Corporation
  • 10.6. Hologic, Inc.
  • 10.7. Koninklijke Philips N.V.
  • 10.8. Fujifilm Holdings Corporation
  • 10.9. Shimadzu Corporation
  • 10.10. Mindray

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us